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Ubiquinone (UQ), also referred to as coenzyme Q, is a wide-
spread lipophilic molecule in both prokaryotes and eukaryotes
in which it primarily acts as an electron carrier. Eleven proteins
are known to participate in UQ biosynthesis in Escherichia coli,
and we recently demonstrated that UQ biosynthesis requires
additional, nonenzymatic factors, some of which are still
unknown. Here, we report on the identification of a bacterial
gene, yqiC, which is required for efficient UQ biosynthesis, and
which we have renamed ubiK. Using several methods, we dem-
onstrated that theUbiK protein forms a complexwith theC-ter-
minal part of UbiJ, another UQ biogenesis factor we previously
identified. We found that both proteins are likely to contribute
to global UQ biosynthesis rather than to a specific biosynthetic
step, because both ubiK and ubiJmutants accumulated octapre-
nylphenol, an early intermediate of the UQ biosynthetic path-
way. Interestingly, we found that both proteins are dispensable
for UQ biosynthesis under anaerobiosis, even though they were
expressed in the absence of oxygen. We also provide evidence
that the UbiK–UbiJ complex interacts with palmitoleic acid, a
major lipid in E. coli. Last, in Salmonella enterica, ubiK was
required for proliferation inmacrophages andvirulence inmice.
We conclude that although the role of the UbiK–UbiJ complex
remains unknown, our results support the hypothesis that UbiK
is an accessory factor of Ubi enzymes and facilitates UQ biosyn-
thesis by acting as an assembly factor, a targeting factor, or both.
Isoprenoid quinones are conserved in almost all living organ-
isms and functionprimarily as electron andproton transporters
in photosynthetic and respiratory chains (1). Quinones are
composed of a polar redox-active head group coupled to a lipid
side chain, which varies in both length and degree of saturation
(1). Menaquinone (MK)4 and ubiquinone (UQ) are the main
isoprenoid quinones and differ with respect to the structure of
the head group, a naphthalene ring (in MK) and a benzene ring
(in UQ). MK is present in both bacteria and archaea, whereas
UQ is restricted to-,-, and-proteobacteria but is also found
in eukaryotes (1–3). It is now commonly accepted that MK
arose before UQ (4, 5). MK and demethylmenaquinone (DMK)
function predominantly in anaerobic respiratory chains,
whereas UQ is the major electron carrier used for reduction of
oxygen by cytochrome oxidases (1). Quinone biosynthesis has
been extensively studied in Escherichia coli but is still incom-
pletely characterized. The octaprenyl side chain is common to
UQ and (D)MK, and chorismate is the precursor of the benzo-
quinone and napthoquinone rings.
The enzymes catalyzing the different steps of UQ biosynthe-
sis have been described (6). They catalyze the functionalization
(prenylation, decarboxylation, hydroxylation, andmethylation)
of the phenyl ring of the 4-hydroxybenzoate precursor. In total
11 proteins, named from UbiA to -J and UbiX are required for
UQ biosynthesis. The hydroxylases UbiI, UbiF, and UbiH use
dioxygen as a co-substrate and are therefore active only in
aerobic conditions (7, 8). The hydroxylases that participate
in anaerobic UQ biosynthesis have yet to be identified (6). It
is noticeable that only UbiE, a methylase, participates in both
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UQ and MK biosynthesis. Our recent investigations demon-
strated that UQ biosynthesis requires additional factors that
seem not to carry out enzymatic function. For example, we
have recently discovered that UbiJ is required for UQ bio-
synthesis in aerobic conditions in both E. coli and Salmo-
nella enterica (9). However, the role of UbiJ in UQ biosyn-
thesis remains enigmatic.
In the present study, we discovered a novel gene, namely
yqiC, important for UQ biosynthesis under aerobiosis in E. coli
and S. enterica. Contrary to a recent report (10),MKbiosynthe-
sis was not impaired in the yqiCmutant. We therefore propose
to change the name of yqiC to ubiK. The protein from E. coli
was characterized biochemically and structurally. Interestingly,
we demonstrate that UbiK physically interacts with UbiJ and
forms an UbiK2–UbiJ1 complex. A Salmonella ubiK mutant is
growth-deficient under aerobic conditions and the defect is
exacerbated at higher temperatures. Consistently, Salmonella
ubiK mutant is defective for proliferation in macrophages and
mice infection. Overall, our results demonstrate the implica-
tion of UbiK in aerobic UQ biosynthesis and provide an addi-
tional illustration of the importance of UQ for pathogenic bac-
teria proliferation.
Results
ubiK is a new gene involved in aerobic UQ8 biosynthesis
A high-throughput study previously analyzed the growth of
E. coli strains from the Keio single gene deletion library inmore
than 300 conditions and established a phenotypic signature for
each mutant strain (11). Functional connection between genes
with correlated phenotypic signatures could be predicted
and the phenomic profiles of most ubi mutants were in-
deed highly correlated (http://ecoliwiki.net/tools/chemgen/)5
(11). Interestingly, the ubiImutant had the highest correlation
coefficient with the yqiC mutant (hereafter called ubiK),
prompting us to investigate whether ubiK might play a role in
UQ8 biosynthesis.
The ubiKmutant had no growth defect in LBmedium under
aerobic conditions (supplemental Fig. S1A). Its UQ8 content, as
determined by HPLC analysis coupled to electrochemical
detection (ECD), decreased down to 18% compared with the
wild-type strain (Fig. 1,A andB). Complementation of the ubiK
mutant with a plasmid carrying ubiK restored the wild-type
UQ8 level (Fig. 1, A and B). DMK8 and MK8 were optimally
detected at 247 nm (supplemental Fig. S1B) and we found that
the levels of DMK8 were unchanged in the ubiK mutant (Fig.
1C), whereas those of MK8 increased slightly (Fig. 1D). HPLC
chromatograms recorded at 275 nm showed a compound that
eluted at 6.4 min, right after UQ8 in the ubiK mutant (supple-
mental Fig. S1C). Mass spectrometry analysis revealed a main
peak atm/z 656.5 (M NH4) consistent with octaprenylphe-
nol (OPP, C46H70O) (supplemental Fig. S1D). The accumula-
tion of OPP, an intermediate in the biosynthesis of UQ8, has
been observed previously in several ubi mutants deficient in
UQ8 (12, 13). The increased level of OPP in the ubiKmutant
was diminished to the WT level upon transformation by the
plasmid carrying ubiK (Fig. 1E), showing that OPP accumula-
tion correlated with UQ8 deficiency. The UQ8 content of the
ubiK mutant strain after anaerobic growth in LB was found to
be similar to WT (Fig. 1F). Finally, via insertion of a sequential
affinity purification tag (SPA tag) at the 3 end of the ubiK gene
in the E. coli chromosome, UbiK levels were quantified by
Western blot analysis after growth under aerobic and anaerobic
conditions.We also analyzed the levels of SPA-taggedUbiE and
UbiJ. Levels of the three proteins were not influenced by the
growth conditions (Fig. 1G). This result was consistent with a
recent study, which demonstrated that ubiJ and ubiK genes
were regulated neither by Fnr nor ArcA, two major transcrip-
tion factors that respond to oxygen levels (14). Altogether, our
results showed that deletion of the ubiK gene impacts UQ8
biosynthesis in aerobic conditions but does not decrease
(D)MK biosynthesis.
UbiK is almost exclusively present in Proteobacteria
E. coli UbiK (UniProtKB entry Q46868) is a 96-residue pro-
tein that belongs to the BMFP (Brucella membrane fusogenic
protein) superfamily (Pfam PF04380). Bioinformatics analysis
revealed that the 596 members of the BMFP family known to
date (Pfam 30.0, March 2017, http://xfam.org/)5 are almost
exclusively found in -, -, and -proteobacteria, where UQ8 is
present (Ref. 40 and supplemental Fig. S2). Interestingly, ubiK
sequences are not found in the archaebacterial kingdom where
MK is themajor quinone (1). This exclusive presence of ubiK in
the proteobacteria phylum is consistent with the involve-
ment of ubiK in UQ8 biosynthesis and not in MK biosynthe-
sis. An alignment of a subset of UbiK sequences from diverse
proteobacteria species is shown in supplemental Fig. S3. The
average sequence identity of all proteins from this family is
34%. One should note that the C-terminal end of UbiK
sequences, corresponding to the last 16 amino acid residues
in the E. coli protein, is poorly conserved among all different
species. Consistent with this, we found the deletion of the C
terminus (residues 81–96) had no effect on UbiK function
because this construct yielded wild-type levels of UQ8 in the
ubiK strain (not shown).
UbiK forms a trimer
The ubiK gene from E. coliwas cloned without any tag into a
pACYCDuet-1 plasmid and the protein was over-expressed in
the BL21(DE3) E. coli strain. High yield of pure and soluble
UbiK could be obtained (10 mg/liter of culture). To determine
its absolute molar mass, multi-angle light scattering coupled to
size exclusion chromatography (SEC-MALS) experiments
were performed.UbiK showed a single homogeneous peakwith
a molecular mass of 32 kDa (Rh 2.9 0.08 nm), thus corre-
sponding to a trimer (molecular mass for monomer  11.3
kDa), with an elongated hydrodynamic shape (f/f0  1.5) (Fig.
2A). Its secondary structure was analyzed by circular dichroism
(CD) spectroscopy. The CD spectrum of UbiK exhibited two
minima at 208 and 222 nm, indicating the prevalence of helices
(Fig. 2B). Analysis of the spectrum using K2D3 and CDSSTR
softwares allowed to estimate the percentage of helical struc-
ture of 52–55%, random coils of 42–45%, and -sheets of
5 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
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3–4%. Using analytical ultracentrifugation with fluorescence
detection, a trimeric oligomer was observed at a concentration
down to 250 nM, at which point the protein aggregates sug-
gested it is unstable as a monomer. A thermal unfolding exper-
iment was performed by monitoring the CD spectrum of UbiK
as a function of temperature (supplemental Fig. S4). The mid-
point of the unfolding transition (TM) was 66.5 0.1 °C and the
observed conformational transitions were fully reversible,
which allowed us to determine the Van’t Hoff enthalpy of
unfolding, H 250.6 2 kJ/mol. These values are indicative
Figure1.A,HPLCECDanalyses of lipid extracts from1mgof E. coliWTorubiK cells transformedwith either the emptypKvector (vec) or thepKvector carrying
theubiKgenegrown in LBmedium in aerobic conditions. The chromatograms are representative of three independent experiments. Thepeaks corresponding
to UQ8, DMK8, OPP, and the coenzymeQ10 (UQ10) standard are indicated. B, quantification of cellular UQ8 content of the E. coli strains described in A based on
ECD signal (peak area). C and D, quantification of cellular DMK8 and MK8 from chromatograms at 247 nm (see supplemental Fig. S1B). E, quantification (peak
area) of OPP from chromatograms at 275 nm (see supplemental Fig. S1D). B–E, mean  S.E.; n  3–5; ***, p  0.001; ****, p  0.0001, one-way analysis of
variance. F, ECDquantificationof cellularUQ8 content of the E. coliWTandubiK cells grown in anaerobic conditions in LBmedium;n3.G, immunodetection
of SPA-tagged proteins UbiE, UbiK, and UbiJ after growth in LB medium under aerobic (O2) or anaerobic (O2) conditions. Equal loading was verified with
immunodetection of the protein LamB and staining of the SDS-PAGE with Coomassie Blue dye.Mw, molecular mass.
Figure 2. A, SEC-MALS analysis of UbiK from E. coli (injection of 100 l of UbiK at 2 mg/ml on a Superdex 200 10/300 GL increase column, 50 mM Tris-HCl, 150
mMNaCl buffer, pH 7.5. Solid and blue lines correspond to refraction index signal andmolar mass, respectively. B, far-UV circular dichroism spectrum (185–260
nm) of E. coli UbiK (50 mM Tris-HCl, 150 mM NaCl buffer, pH 7.5).
UbiK and ubiquinone biosynthesis
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of a very stable protein, in accordance with a coiled-coil protein
structure (15).
Structural model of UbiK
UbiK and human Brick1 share 25% sequence identity.
Human Brick1 (UniProtKB entry Q8WUW1) forms the core
subunit of the Wave (Wiskott-Aldrich VErprolin proteins)
complex involved in actin polymerization. Brick1 contributes
to the architecture of the complex by serving as a platform on
which the four other proteins assemble. To gain insights into
the structural organization of the UbiK trimer, a structural
model was generated using Swiss-Model (http://swissmodel.
expasy.org/). The PDB codes for the main templates used
were: 3PP5 (Brick1 from Dictyostelium discoideum), 3P8C
chain E (Brick1 from Homo sapiens), and 4LL7 (She3p from
Saccharomyces cerevisiae) (16). When purified alone, Brick1
assembles as an -helical triple coiled-coil along a well con-
served hydrophobic patch (17) (Fig. 3A). The hydrophobic
core of the Brick1 trimer bundle is also seen within the UbiK
sequence (supplemental Fig. S3). The best model of UbiK
monomer calculated with Swiss-Model thus consisted of two
long aligned  helices connected by a loop in the central core
of the protein and disordered domains at the N- and C-ter-
minal ends (Fig. 3B). The secondary structures contents of
this model matched the ones determined by circular dichr-
oism (Fig. 2B): 	53% of -helices and 47% of random coils.
On this basis we propose a model for the UbiK homotrimer,
displaying the same fold as the triple coiled-coil structure in
Brick1 (Fig. 3C).
UbiK interacts with other Ubi proteins
To answerwhetherUbiK interacts with otherUbi proteins in
vivo, we used the bacterial BACTH two-hybrid reporter system
that monitors both direct and indirect interactions. This
method is based on functional complementation between
adenylate cyclase fragments T18 and T25 expressed from two
compatible plasmids (18). Adenylate cyclase activity is restored
only when proteins fused to T18 and T25 interact. In line with
our results about the oligomerization of UbiK, it was found to
interactwith itself (Fig. 4,A andB). In addition,UbiK interacted
with the following Ubi proteins: UbiB, -E, -F, -G, -H, -I, -J, and
-X (Fig. 4, A and B). More specifically, UbiK interacted with
UbiE, -F, -G, -H, -I, -J, -K, and -X proteins regardless of whether
Figure 3. A, crystal structure of the -helical coiled-coil Brick1 homotrimer from D. discoideum (PDB code 3PP5); B, predicted structural model of E. coli UbiK
(Swiss model); C, hypothesized model of the -helical coiled-coil UbiK homotrimer, based on sequence identity, CD, and SEC-MALS. N and C termini are
predicted as disordered regions.
Figure 4. Interactions betweenUbiK and the other Ubi proteins.A bacte-
rial two-hybrid systemwasused todetect in vivoprotein-protein interactions.
Values of -galactosidase activities, calculated in Miller units, with standard
errors are shown: pT25-ubiK (A) or pT18-ubiK (B) were analyzedwith ubiJ, -E, -I,
-K, -B, -D, -G, -A, -X, -H, or -F genes, respectively.
UbiK and ubiquinone biosynthesis
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it was fused to the T18 or T25 proteins. UbiK also interacted
with UbiB but only when it was fused to the T18 moiety. Last,
UbiK failed to interactwithUbiA,UbiC, andUbiD (Fig. 4,A and
B). Altogether, these results suggested that UbiK plays a pivotal
role in E. coli UQ8 biosynthesis.
UbiK interacts directly with UbiJ
To further substantiate the idea that UbiK had a pleiotropic
role in UQ8 biosynthesis, we used co-expression and co-purifi-
cation assays to test the connection between UbiK and other
Ubi proteins. For this we choose a subset of Ubi candidates
among those suggested to partner with UbiK by the bacterial
two-hybrid assay above. Likewise, UbiG, -J, -X, -E, and -J were
fused to a His6 tag and UbiK to an S tag. Soluble fractions con-
taining the His6-tagged proteins were purified on nickel-nitri-
lotriacetic acid resin, and UbiK was detected exclusively in
extracts containing UbiJ–His6 (Fig. 5A). Interactions between
the UbiK and UbiJ proteins were further investigated using
pulldown assays. ubiK, ubiJ, and sufC (used as a negative con-
trol) genes were fused at their 5-end with themalE gene. The
chimeric proteins, MBP–UbiK and MBP–SufC, were purified
in strains carrying a chromosomal copy of the his6–ubiJ gene,
whereas on the other hand MBP–UbiJ and MBP–SufC were
purified from a strain containing an ubiK–SPA gene. Soluble
extracts of each strain were loaded on an amylose column. The
column was then extensively washed and finally a solution of
maltose (10 mM) was applied. MBP–UbiK and His6–UbiJ
were co-eluted (Fig. 5B, lane 2) as MBP–UbiJ and UbiK–SPA
(Fig. 5B, lane 4). MBP–SufC was always eluted alone (Fig. 5B,
lanes 1 and 3). His6–UbiJ and UbiK–SPA were identified by
immunoblotting using anti-His (Gene Tex) and anti-FLAG
(Sigma) antibodies, respectively. Thus, biochemical analyses
allowed us to confirm that UbiK interacts with UbiJ. Last,
yeast two-hybrid-based tests were run as they report on
direct interactions and might eventually allow to pinpoint
zones of interaction. Evidence of an UbiK–UbiJ direct inter-
action was found to depend on the C terminus 50 amino
acids of UbiJ only (UbiJ(151–201)) (Fig. 5C). No interaction
was observed using the N terminus part of UbiJ (data not
shown). Altogether, these results established unambiguously
that UbiK and UbiJ interact specifically and form a complex
in vivo.
Biochemical characterization of the E. coli UbiK–UbiJ complex
E. coli UbiK and UbiJ were co-expressed in E. coli BL21
strain, using the T7 promoter pETDuet-1 expression vector. A
Figure 5. A,UbiJ-His and UbiK-S tag were co-expressed from the pETDuet-6his-ubiJ/ubiK-S tag plasmid. Cell extracts were passed over a nickel-nitrilotriacetic
acid column. Imidazole gradient was applied and the two proteins were co-eluted. Lane 1, soluble cell extract; lane 2, flow through; lane 3, wash; lanes 4–9,
imidazole eluted peak fractions. B, pulldown assays were carried out to investigate the interactions between the UbiK and UbiJ proteins. ubiK, ubiJ, and sufC
(negative control) genes were fused at their 5 end with themalE gene and the chimeric proteins were purified in His6–ubiJ (lanes 1 and 2) or ubiK–SPA (lanes
3 and 4) backgrounds. Soluble extracts of each strain were loaded onto an amylose column, the column was washed and a solution of maltose was applied.
MBP–UbiK and His6–UbiJ were co-eluted (lane 2) as MBP–UbiJ and UbiK–SPA (lane 4). C, interactions between UbiK and UbiJ (top), UbiK and the 50 C-terminal
amino acids of UbiJ (middle), andUbiK and an empty plasmid (bottom) were analyzed by a yeast two-hybrid reporter system. Diploid strains producing pairs of
Ubi proteins were tested on solid medium for activation of the lacZ gene and the intensity of interaction was monitored by a gradient from dark blue (strong
interaction) towhite (no interaction) (left). The ability to grow on selective medium lacking leucine was also monitored during 16 h at 30 °C (right).
UbiK and ubiquinone biosynthesis
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two-step purification consisting of an affinity column (His Trap
HP) followed by size exclusion chromatography (HiLoad
16/600 Superdex 200 pg) resulted in three well separated pro-
tein peaks (supplemental Fig. S5). The low-molecular mass
peak, called P3, with a molar mass of 	18–20 kDa based on
SDS-PAGE, was analyzed by ESI-MS and peptide mass finger-
print (supplemental Fig. S6). P3 did not contain any UbiK pro-
tein but only two main fragments of UbiJ: one major species
lacking the last 56 C-terminal residues (UbiJ(146–201)) and
one minor species, lacking the last 63 C-terminal residues
(UbiJ(138–201)) (supplemental Figs. S5 and S6). These trun-
cated forms are most likely a result of proteolysis during puri-
fication. In contrast, the first (minor, P1) and the second (major,
P2) peaks contained both UbiK and UbiJ in seemingly different
ratios. They were both subjected to SEC-MALS and analytical
ultracentrifugation. SEC-MALS analysis of P2, eluting at 13.4
ml, led to a single molar mass (49 kDa) with a hydrodynamic
radius of 3.6  0.4 nm and a frictional ratio f/f0 of 1.7 that
matches an elongated heterocomplex of two monomers of
UbiK (28 kDa) and one monomer of UbiJ (21 kDa) (Fig. 6A).
Sedimentation velocity experiments revealed three different
species, with the sedimentation coefficients: 2.8 s20,w (	60%),
corresponding to a 2:1 UbiK–UbiJ complex; 3.8 s20,w (	20%);
5.6 s20,w (	10%) corresponding to larger oligomeric species
(supplemental Fig. S7A). The stoichiometry of the dominant
species remained unchangedwith increased protein concentra-
tions (supplemental Fig. S7B), indicating a stable UbiK–UbiJ
(2:1) heterocomplex. P1 eluting at 12.8 ml (Fig. 6B) consists
mainly of two species: the minor component is UbiK
homotrimer and the major component is a heterotrimer of
UbiK–UbiJ (2:1). Evidence for the presence of the UbiK
homotrimer in P1 is given by sedimentation velocity experi-
ments. The 2.2 s20,w species in P1 is only seen by interference
(supplemental Fig. S7C), and not in absorbance (supplemental
Fig. S7D), thus indicating the presence of UbiK only, and has
furthermore, a sedimentation coefficient similar to that of the
homotrimeric UbiK (2.1 s20,w) (supplemental Fig. S7E). The
heterotrimer of UbiK–UbiJ in P1 has a different sedimentation
coefficient (3.2 s20,w) than the main species in P2 (2.8 s20,w)
probably due to having a different 3D conformation. This is
further suggested by the varying frictional ratio seen between
P2 and P1, 1.80 f/f0 and 1.55 f/f0, respectively. This higher fric-
tional ratio seen for P2 highlights its more elongated form and
explains the higher sedimentation coefficient.
Figure 6. SEC-MALS analysis of the two complexes P1 (A) and P2 (B) of UbiK–UbiJ. Samples were run on a Superdex 200 Increase 10/300 GL. Blue, red, and
green curves correspond to the molar masses of the UbiK–UbiJ complex, UbiK and UbiJ, respectively (protein-conjugate method). C, crystal structure of the
sterol carrier protein SCP2 from Yarrowia lipolytica, with palmitic acid ligand. D, hypothesized model of the E. coli UbiK–UbiJ 2:1 heterotrimer complex, made
by Phyre 2. UbiJ monomer is colored orange, UbiK dimer is colored blue and red. The template for the N-terminal domain of UbiJ(1–120) was PDB 4JGX (SCP2
from Y. lipolytica); the template for the C-terminal domain (151–195) was PDB 3QH9 (human coiled-coil liprin) and the template for the middle domain
(132–150) was PDB 1M1J (fibrinogen  subunit).
UbiK and ubiquinone biosynthesis
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To further confirm the UbiJ C-terminal interaction with
UbiK, we produced three plasmids encoding UbiK without
an S tag alongside three truncated versions of UbiJ (His tag),
UbiJ(121–201), UbiJ(1–120), and UbiJ(1–145) (supple-
mental Fig. S8). Upon coexpression and purification of UbiK
and UbiJ truncations by nickel affinity column, we observed
that the C terminus of UbiJ (UbiJ(1–120) and UbiJ(1–145))
is essential for binding UbiK and that the N terminus
(UbiJ(121–201)) is not able to bind UbiK. These in vitro
results confirm the in vivo double hybrid assays (Fig. 5C) that
show that only the C terminus is responsible for UbiK binding.
In the absence of a three-dimensional structure, we also built
a model for the heterotrimer UbiK–UbiJ complex. Sequence
homologies between UbiK and Brick1 and between UbiJ and
Sterol Carrier Protein (SCP-2) proteins (supplemental Fig. S9
and 6C), which are intracellular lipid transfer proteins, as well
as in silico structural predictions allowed us to propose the
model shown in Fig. 6D. In this model the UbiK–UbiJ 2:1 het-
erocomplex results from the formation of a three-helix bundle
between two monomers of UbiK and the -helical C terminus
of onemonomer of UbiJ, in full agreement with the latter being
responsible for UbiJ binding to UbiK.
UbiK–UbiJ bind lipids
E. coli UbiJ is made of an N-terminal sterol carrier protein
(SCP-2) domain (1–120) and a putative C-terminal coiled-coil
domain (121–201) (supplemental Fig. S9). SCP-2, also known
as nonspecific lipid transfer protein, is a small ubiquitous pro-
tein of unknown function. Several existingX-ray orNMRstruc-
tures of SCP-2 proteins revealed the protein accommodates an
internal and hydrophobic cavity suitable for lipid binding (19–
23). As a matter of fact, fatty acid molecules, such as palmitic
and stearic acids, were observed in the various SCP-2members.
Therefore, we tested if a lipid molecule might be bound to the
purifiedUbiK–UbiJ complex. The purifiedUbiK–UbiJ P2 com-
plex was treated with methanol, heated at 95 °C, and centri-
fuged. The supernatant was then injected onto an ESI/MS
apparatus equipped with a triple TOF detector in a negative
mode (Fig. 7). Interestingly, in this supernatant amass atm/z
253.22 was identified as palmitoleic acid (commercial standard
m/z 253.23). Palmitoleic acid, (9Z)-hexadec-9-enoic acid, is a
C16 monounsaturated lipid that is largely found in E. coli, along
with other C14 andC18 fatty acids: it represents 35% of the lipids
within the membrane of the bacterium, whereas palmitic acid
represents 45%, vaccenic acid 18%, and myristic acid 2%. Simi-
lar experiments using UbiK alone revealed no lipid binding
(data not shown).
The Salmonella ubiK gene is required for UQ8 biosynthesis,
intracellular proliferation, and virulence inmice
Previously, we found that ubiJ was required for UQ8 biosyn-
thesis and intracellular proliferation in S. enterica (9). Given
the functional interaction between UbiK and UbiJ in E. coli
reported above, we constructed an ubiK mutant in S. enterica
and measured its UQ8 content. Compared with the wild-type
strain, we found a 16-fold decrease in UQ8 when the ubiK
Figure 7. ESI-TOF-MS of UbiK–UbiJ P2 supernatant. The m/z 263.22 seen in the UbiK–UbiJ sample corresponds to the exact mass of palmitoleic acid, m/z
263.23 (commercial standard inset).
UbiK and ubiquinone biosynthesis
J. Biol. Chem. (2017) 292(28) 11937–11950 11943
 at FA
C BIO
LO
G
IA
/BIBLIO
TECA
 on June 24, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
mutant was grown in LB under aerobic conditions (Fig. 8A).
Complementation of this mutant led to an increase of the UQ8
level to	70%of theWT (supplemental Fig. S10A). The levels of
DMK8 andMK8were not significantly different betweenubiK
and WT strains (supplemental Fig. S10B). As already observed
in E. coli, the UQ8 content of the ubiKmutant was not different
from that of the WT after growth in anaerobic conditions (Fig.
8A). Next, RAW 264.7 mouse macrophages were infected with
the wild-type strain and the ubiK mutant. Bacterial prolifera-
tion was assayed by calculating the proliferation index as the
ratio of the number of intracellular bacteria at 16 h post-infec-
tion to that at 2 h post-infection. Because important differences
were found in the function of UQ8 content in the presence or
absence of oxygen, bacterial inoculum were grown either aero-
bically or anaerobically. The ubiKmutant exhibited a prolifer-
ation index 16-fold lower compared with its wild-type parent
with an aerobic inoculum and 3-fold lower with an anaerobic
inoculum (Fig. 8B). Interestingly, the intracellular proliferation
of the ubiKmutant was found to be higher when the infection
was performedwith an anaerobic inoculum (11) comparedwith
an aerobic inoculum (2.5) (Fig. 8B). Because an ubiK mutant
was previously shown to exhibit a thermosensitive phenotype
in Salmonella (24), we monitored the growth of wild-type and
an ubiK mutant at different temperatures and indeed found
that growth impairment was exacerbated at higher tempera-
tures (supplemental Fig. S10C). Thus, to investigate the impact
of the temperature on the intracellular proliferation capacity of
the ubiKmutant, infection of RAW 264.7 mouse macrophages
was carried out at 30 and 37 °C. The proliferation index of the
ubiKmutantwas severely affected comparedwith thewild-type
strain at 37 °C (12-fold), whereas the difference was much
more reduced at 30 °C (2-fold) (Fig. 8C). The UQ8 deficiency of
the ubiK mutant compared with the wild-type strain was less
severe at 30 °C than at 37 °C (9- and 16-fold, respectively) (sup-
plemental Figs. S8A and S10D), which suggest that the
increased proliferation index of the ubiK mutant at 30 °C may
be due to the higher UQ8 content. Last, mixed infections of
mice were carried out using the ubiK mutant and wild-type
strain to determine the competitive index (CI) and compare the
virulence of the two strains (25). Mice were infected intraperi-
toneally and the ubiK mutant was found to be highly affected
for its virulence in the animal (CI  0.0005) (Fig. 8D). Collec-
tively, these results confer to ubiK a key role in UQ8 biosynthe-
sis and in Salmonella virulence.
Discussion
UQ8 acts as a membrane-embedded electron shuttle and is a
key molecule for bacteria to use respiratory metabolism for
growth. Biosynthesis of UQ8 includes a series of enzymatic
steps in which a benzene ring undergoes a series of modifica-
tions (prenylation, decarboxylation, methylation, and hydrox-
ylation). Recently, however, we obtained evidence that non-
enzymatic biogenesis factorsmight also be required. Indeed, we
identified UbiJ as a new factor involved in UQ8 biosynthesis in
E. coli and Salmonella under aerobiosis (9). In the present
study, we identified an additional new biogenesis factor, called
UbiK, which is also required for UQ8 biosynthesis and is
unlikely to carry out any enzymatic function. Phenotypic and
biochemical characterization revealed that UbiK and UbiJ
function as a complex that contributes to as yet unclear step(s)
in UQ8 biosynthesis. We collected evidence that allow us to
discuss their possible role in helping other enzymatic Ubi pro-
teins to carry out their function.
Our results and interpretation differ from a recent study that
concluded that UbiK was involved in MK biosynthesis in Sal-
monella (10). This conclusion was based on an analysis of the
quinone content of an ubiK mutant. We did not confirm such
results as, in our analysis, the levels of (D)MK8 were not
decreased in the ubiK mutant compared with the wild-type
strain in both E. coli and S. enterica Typhimurium. We believe
that this discrepancy is due to the erroneous identification of
Figure8.A,UQ8 content of S. entericaWTandubiK cells after growthat 37 °C
in LB medium in aerobic (O2) or anaerobic conditions. Mean S.E.; n 4; ns,
nonsignificant; ****, p  0.0001, unpaired two-tailed t test. B and C, Salmo-
nella strains (WT and ubiK) were grown overnight under aerobic (gray bars,
B) or anaerobic conditions (black bars, B) in LB at 37 °C. Opsonized bacteria
were phagocytosed by RAW 264.7 cells. The experiments were carried out at
37 °C (gray bars,C) or 30 °C (black bars,C). Two and 16hpost-infection,mouse
macrophages were lysed for enumeration of intracellular bacteria (gentami-
cin-protected) determined by colony-forming unit (cfu) counts. The values
shown represent the proliferation index calculated as a ratio of the intracel-
lular bacteria between 16 and 2 h postinfection. Results are the mean S.D.
of at least three independent experiments each in triplicate.Asterisks indicate
a statistically significant difference between the ubiK mutant and the WT. *,
p 0.05 (Mann-Whitney U test). D, BALB/c mice were inoculated intraperito-
neally with a 1:1 mixture of ubiK mutant and wild-type Salmonella strains.
Forty-eight hours post-inoculation, spleens were harvested for bacterial
counts. Competitive indexes of wild-type versus ubiK mutant strains in mice
were determined. Each circle represents one mouse and the horizontal bar
corresponds to themean.Aone-sample t testwasused todeterminewhether
the CI was significantly different from 1. ***, p 0.001.
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Salmonella endogenous MK8 in the HPLC chromatograms by
Wang et al. (10). Indeed, these authors used commercial vita-
min K2 (MK4) as a standard to identify the retention time of
MK8 in chromatograms of Salmonella lipid extracts, whereas
MK4 andMK8 have an entirely different retention time on C18
columns.
The occurrence of anUbiK–UbiJ complexwas demonstrated
by using multiple molecular, biochemical, and physical meth-
ods. Besides all evidences for the occurrence of an UbiK–UbiJ
complex, we noticed marked changes in the behavior of UbiJ
and UbiK depending on whether the proteins were overex-
pressed individually or together. Indeed, whereas UbiK alone is
a trimer, it is converted to a dimer upon interaction with one
UbiJ monomer, and whereas UbiJ is insoluble on its own it is
perfectly soluble when interacting with UbiK. In the absence of
a three-dimensional crystal structure, we are able to propose a
model for that complex. In this model a UbiJ monomer and
UbiK dimermake a heterotrimeric complex allowed by the for-
mation of a three-helix bundle from two monomers of UbiK
and the helical C terminus of UbiJ.
Human Brick1 (UniProtKB entry Q8WUW1) forms the core
subunit of the Wave (Wiskott-Aldrich VErprolin proteins)
complex involved in actin polymerization. Interestingly, the
400-kDa Wave complex consists of five proteins and Brick1
(HSPC300) contributes to the architecture of this mega com-
plex by serving as a platform to the other proteins (16). On this
basis, one can speculate that UbiK, and by extension the UbiK–
UbiJ complex, might participate to some sort of platform. Such
a role would be consistent with the fact that none of them are
predicted to carry out an enzymatic function, and that inacti-
vation of both drastically reduces the level of UQ8 but lead only
to the accumulation of the early intermediate OPP, which is
not diagnostic of a defect in a specific biosynthetic step. The
hypothesis that all Ubi enzymes are part of, and function as a
mega complex has received some support in bacteria and is well
established in eukaryotes (26–28). That the UbiK–UbiJ is
instrumental in the formation of such a complex is supported
by data of the bacterial two-hybrid analysis. Indeed, UbiK was
found to be connected, directly or not, with most Ubi proteins.
Hence it is tempting to think of the UbiK–UbiJ complex as a
facilitator of the formation (folding, assembly, and nucleation)
of a Ubi mega complex. Another possibility, which is not exclu-
sive from the one just discussed, is that UbiK–UbiJ helps loca-
tion or interaction of the Ubi enzymes with the membrane.
Indeed, a conundrum is that whereas UQ8 biosynthesis must
take place within the membrane environment, only one of the
Ubi proteins, UbiA, is actually membrane-bound. The obvious
need of locating the Ubi enzymes or complex to the membrane
could be fulfilled by the UbiK–UbiJ complex. This putative
function is consistent with our demonstration that UbiK–UbiJ
is able to bind lipids.
During the course of the infection, Salmonella can be
exposed to different stressful conditions and must negotiate
anaerobic and aerobic environments (29). In this work, we pro-
vided evidence that UbiK is required for full multiplication in
macrophages and full virulence in mice. This is in agreement
with a previous study by Carrica et al. (24) who reported that
ubiKwas important for Salmonella virulence in amousemodel.
However, because the ubiK mutant exhibits a thermosensitive
phenotype, it is difficult to sort out the global defect from the
specific contribution to virulence. Interestingly, we found
the ubiK mutant proliferation to be partially recovered when
the bacterial inoculum was grown anaerobically or when the
infection was carried out at 30 °C, two conditions during which
UQ8 levels increased in the ubiK background. This is both con-
sistent with our previous proposal for a requirement of UQ8 for
an efficient intracellular proliferation and in support of the
hypothesis that Salmonella intracellular lifestyle relies on aer-
obic respiration and oxygen availability to survive and prolifer-
ate within host cells.
Experimental procedures
Bacterial strains and growth conditions
E. coli strains were grown in Luria-Bertani (LB) medium at
37 °C in Erlenmeyer flasks filled to 1/10 of the maximal volume
and shaken at 150 rpm (aerobic conditions). For anaerobic
growth, Hungate tubes were used and the LB medium was
extensively degassed with argon before the tubes were closed
and autoclaved. Cultures were inoculated through the septum
of the Hungate tube with a syringe fitted with a sterile needle.
Ampicillin (50 g/ml), kanamycin (25 g/ml), and chloram-
phenicol (25 g/ml) were added when needed. Deletion of var-
ious genes and concomitant insertion of an antibiotic resistance
cassette was carried out using -Red-mediated recombination
(30). Mutations were moved to the wild-type E. coli strain
MG1655 by P1 transductions and to the wild-type S. enterica
strain 12023 by P22 transductions.
Plasmid constructions
The ubiK and ubiJ inserts were obtained by PCR amplifica-
tion using MG1655 as template and the oligonucleotides
5-EcoRI-ubiK/3-XhoI-ubiK and 5-EcoRI-ubiJ/3-XhoI-ubiJ,
respectively. ubiK and ubiJ inserts were EcoRI-XhoI digested
and inserted into EcoRI-SalI-digested pTrc99A or pBAD24
plasmids, yielding the pTrc-ubiK and pTrc-ubiJ plasmids or
pA-ubiK and pA-ubiJ plasmids, respectively.
To overproduce MBP–UbiK and MBP–UbiJ, the ubiK and
ubiJ genes were cloned into the pMal-c2 vector downstream of
the Ptac promoter. The ubiK and ubiJ inserts were obtained by
EcoRI-HindIII digestion of the pTrc-ubiK and pTrc-ubiJ plas-
mid and the restricted fragments were inserted into EcoRI-
HindIII-digested pMal-c2, yielding pMal-ubiK and pMal-ubiJ.
The pEG202 and pJG4–5 vectors were used to express UbiK,
UbiJ, and UbiJ50aa proteins fused to the DNA-binding protein
LexA and to the transcriptional activation motif B42, respec-
tively. The inserts were obtained by PCR using MG1655 chro-
mosomal DNA as a template and 5-EcoRI-ubiK/3-XhoI-ubiK,
5-EcoRI-ubiJ/3-XhoI-ubiJ, and 5-EcoRI-ubiJ50aa/3-XhoI-ubiJ
primers. The inserts were digested by EcoRI-XhoI. The
restricted ubi genes containing inserts were cloned into the
EcoRI-XhoI-digested pEG202 and pJG4-5, yielding the pB42
and pLexA plasmid series, respectively.
To construct pETDuet-ubiK-S-tag. The coding sequence of
theE. coli ubiK genewas PCR amplified fromanMG1655 strain
by using the 5-NdeI-ubiK and 3-XhoI-del-stop-ubiK primers,
digested using NdeI and XhoI, and cloned into pETDuet-1,
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yielding pETDuet-ubiK-S-tag. To construct pETDuet-ubiK-
no-tag, the ubiK gene was PCR amplified by using the 5-NdeI-
ubiK and 3-XhoI-ubiK primers, digested using NdeI and XhoI,
and cloned into pETDuet-1, yielding pETDuet-ubiK-no-tag.
ubiJ insert was obtained by EcoRI-HindIII digestion of the
pTrc99A-6his-ubiJ vector. The restricted fragment was
inserted into pETDuet-ubiK-S-tag EcoRI-HindIII-digested,
yielding pETDuet-6his-ubiJ/ubiK-S-tag.
To modify pETDuet-6his-ubiJ/ubiK-S-tag and remove the S
tag, a TGA stop codon was inserted using 5-ubiKstop and
3-ubiKstop primers. The pETDuet-6his-ubiJ/ubiK (without S
tag) was used to generate the three pETDuet-ubiJ truncated
versions: UbiJ(121–201), UbiJ(1–120), and UbiJ(1–145).
All pETDuet plasmids versions were verified by DNA sequenc-
ing and then transformed into E. coli BL21(DE3).
Strain construction
The yqiC::Kan mutation from the BW25113 strain (Keio
library) was transduced into a MG1655 strain by P1 trans-
duction. To build the His6-ubiJ strain, an insert carrying the
lacZ-aadA7(SpcR)-ptac-His6-ubiJ-lacZ gene was obtained
after PvuII-ScaI digestion of the pGEMT-aadA7(SpcR)-ptac-
His6-ubiJ vector. In the resulting fragment, theHis6-ubiJ gene is
under control of the Ptac promoter. Replacement of the lacZ
allele by the LacZ-aadA7(SpcR)-ptac-His6-ubiJ-LacZ gene was
carried out in the ubiJ strain as described by Datsenko and
Wanner (30).
TheDY330ubiC-SPA strain encompassing the SPA tagDNA
sequence and the kanamycin antibiotic resistance marker cas-
sette (KanR) was used as a template in polymerase chain reac-
tion (PCR) amplification. A 5-ubiK-SPA gene-specific forward
primer, located immediately upstream of the ubiK gene stop
codon, and a 3-ubiK-Kan gene-specific reverse primer, located
immediately downstream of the target gene stop codon, were
used to amplify the SPA tag and KanR cassette. The purified
PCR product is subsequently targeted to integrate at the 3 end
(immediately upstream of the native stop codon) of an ubiK
gene in the BW25113 strain in which the -Red recombination
machinery is expressed. The ubiK–SPA–Kan was transduced
through P1 phage from BW25113 to MG1655.
Analyses of the quinone content
Quinone extraction and quantification by HPLC-ECD anal-
yses were performed as previously described (31). UQ10 was
used as a standard and a precolumn guard cell set at650 mV
allowed the quinones to be detected in their oxidized form.
ECD was performed with a Coulochem III (Thermo Fisher)
equipped with a 5011A analytical cell (E1,650 mV; E2,650
mV), and UV detection at multiple wavelengths was performed
with a diode array detector. The peaks forDMK8 andMK8were
integrated from the 247-nm chromatograms and for OPP from
the 275-nm chromatograms. Similarly to the UQ8 signal, the
peak areas were corrected for sample loss during the lipid
extraction based on the recovery of the UQ10 standard and val-
ues were expressed permg of cell wet weight.Whenmass spec-
trometry (MS) detection was needed, the flowwas divided after
the diode array detector with an adjustable split valve (Analyt-
ical Scientific Instruments) to allow simultaneous EC (60% of
the flow) and MS (40% of the flow) detections. MS detection
was performed in positive mode with electrospray ionization
on aMSQ Plus spectrometer (Thermo Fisher). The probe tem-
perature was 450 °C, the cone voltage was 80 V, andMS spectra
were recorded between m/z 600 and 880 with a scan time of
0.4 s.
Western blot analysis
E. coli cellswere harvested in exponential phase, washedwith
PBS buffer, and heated at 95 °C for 10 min in Laemmli buffer.
Equal amounts of E. coli protein extracts were analyzed on a
15% acrylamide SDS-PAGE gel. Immunoblot analyses were
performed with polyclonal antibodies raised against LamB
(courtesy of A. Meinke, Intercell AG), monoclonal antibodies
were raised against the FLAG epitope (Sigma) included in the
SPA tag (32) and monoclonal antibodies raised against the His
epitope (Gene Tex). Immunodetection was performed using
goat anti-mouse HRP-conjugated (Bethyl Laboratories) or goat
anti-rabbit HRP-conjugated (Covalab) and the ClarityWest-
ern ECL substrate (Bio-Rad). Primary antibodies were used
at the following dilutions: anti-LamB, 1/2000, and anti-
FLAG epitope, 1/5000.
Bacterial two-hybrid reporter system
The bacterial two-hybrid reporter system is based on func-
tional complementation between Bordetella pertussis adeny-
late cyclase fragments, T18 and T25, expressed separately from
two compatible plasmid replicons (18). Adenylate cyclase activ-
ity is restored onlywhenproteins fused toT18 andT25 interact.
Functional reconstitution of B. pertussis adenylate cyclase in an
E. coli cya lac strain was monitored by assaying the activity
of a cAMP-CRP-dependent lac promoter of a chromosomally
encoded lac operon. Fusions were constructed with T18 and
T25 present at the N-terminal of Ubi proteins.
Yeast two-hybrid system
The yeast two-hybrid system assay was performed as
described by Golemis et al. (33). The -galactosidase activity
from diploid cells, obtained by mating of strains EGY48 and
RF206 carrying the appropriate plasmid, was detected on plates
containing X-gal (33) and quantified from liquid culture. The
-galactosidase activity was expressed as nanomoles of o-nitro-
phenyl--D-galactoside hydrolyzed permin/mg of protein. The
diploid cells were also assayed for the expression of the Leu
reporter gene. Diploid strains were grown in liquid selective
CMmedium lacking leucine.
Pulldown ofMBP hybrid proteins
MG1655 ubiK–SPA cells transformed with pMal–sufC and
pMal–ubiJ and MG1655 His6–ubiJ cells transformed with
pMal–sufC and pMal–ubiKwere grown at 37 °C in 200ml of LB
medium to an A600 of 1.0. Induction was performed with 0.1
mM IPTG, which was added for 3.5 h at 37 °C. The bacterial
pellet was resuspended in 8 ml of buffer A (100 mM Tris-HCl,
pH 7.5, 50 mM NaCl) and disrupted twice by French pressure
treatment. The cell lysate was centrifuged at high speed for 15
min at 4 °C. Supernatants were added to 300l of amylose resin
(NewEnglandBiolabs). Themixturewas stored for 3.5 h at 4 °C.
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The resin was then washed with 30 resin volumes of buffer A.
The recombinant proteins,MBP–UbiK,MBP–UbiJ, andMBP–
SufC, were eluted with buffer A added with 10mMmaltose. For
detecting His6–UbiJ, 0.5-ml elution fractions concentrated

10 on Microcon (Millipore) were analyzed by immunoblot-
ting using anti-His antibodies (Gene Tex), whereas for detect-
ing UbiK-SPA protein, aliquots of the 0.5-ml fractions were
analyzed using anti-FLAG (Sigma) antibodies.
Expression and purification of UbiK
Overexpression was performed in BL21(DE3) E. coli strain
transformed with pETDuet-ubiK-no-tag. Cells were grown
with shaking (200 rpm) at 37 °C, in LB medium containing
ampicillin (100 g/ml), until they reached A600 nm 0.5, when
overexpression was induced by addition of IPTG (0.4 mM).
After induction, cells were grown for 4 h at 37 °C, and then
harvested by centrifugation at 5000 
 g for 10 min. All subse-
quent operations were carried out at 4 °C. Cells were resus-
pended in 5 volumes of buffer B (50 mM Tris-HCl, pH 7.5, 20
mM NaCl, 1 mM Pefabloc) and lysed by sonication (Branson
Digital Sonifier, Amplitude 40% for 10 min). Nucleic acids
were precipitated by streptomycin sulfate (2% w/v) and the
crude extracts were then submitted to ultracentrifugation at
180,000 
 g for 90 min (Optima XPN-80, rotor 50.2 Ti, Beck-
man Coulter). The resulting supernatant was loaded onto a
Hiprep 26/10 Desalting column (GEHealthcare). The resulting
desalted proteins were loaded onto a Hitrap Q FF (5 ml, GE
Healthcare) equilibrated with buffer A. Bound proteins were
eluted with a gradient of NaCl (0–500 mM) in 50 mM Tris-HCl,
pH 7.5, buffer, and UbiK was eluted at 120 mMNaCl. The most
pure UbiK fractions were pooled and loaded onto a HiLoad
26/600 Superdex 200 pg equilibrated with 50 mM Tris-HCl, pH
7.5, 150 mM NaCl. The elution volume of UbiK was 185 ml.
UbiK fractions were pooled, frozen in liquid N2, then stored at
80 °C.
Expression and purification of UbiK–UbiJ complexes
Overexpression was performed in BL21(DE3) E. coli strains
transformed with pETDuet-6his-ubiJ/ubiK-S-tag. Cells were
grown with shaking (200 rpm) at 37 °C, in LBmedium contain-
ing ampicillin (100 g/ml), until they reached A600 nm  0.4,
when overexpression was induced by addition of IPTG (0.2
mM). After induction, cells were grown for 4 h at 37 °C, and then
harvested by centrifugation at 5000 
 g for 10 min. All subse-
quent operations were carried out at 4 °C. Cells were resus-
pended in 5 volumes of buffer B and lysed by sonication (Bran-
sonDigital Sonifier, Amplitude 40% for 10min). Crude extracts
were then submitted to ultracentrifugation at 180,000
 g for
90min (Optima XPN-80, rotor 50.2 Ti, Beckman Coulter). The
resulting supernatant was loaded onto a Hitrap Chelating HP
column (5 ml, GE Healthcare) equilibrated with buffer A.
Bound proteins were eluted with a gradient of imidazole
(0–500 mM) in buffer, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl.
The most pure UbiK–UbiJ complex fractions were pooled and
loaded onto a HiLoad 26/600 Superdex 200 pg equilibrated
with 50 mM Tris-HCl, pH 7.5, 150 mM NaCl. The fractions
corresponding to peak 1 and peak 2 fractions were pooled, fro-
zen in liquid N2, stored at 80 °C, and then submitted to
SEC-MALS analysis.
Circular dichroism
Circular dichroism in the far-UV region was performed at
20 °C using a spectropolarimeter (Jasco J-810) equipped with a
water-cooled Peltier unit. UbiK spectra were recorded in a
0.01-mmpath length cell (121.QS, Hellma) from 185 to 260 nm
with 11 mg/ml of UbiK sample in 50 mM Tris-HCl, 150 mM
NaCl, pH 7.5, buffer. For each sample, an averaged spectrum
was produced by merging three consecutive scans; the spectra
were corrected using buffer baseline measured under the same
conditions. Data were recorded in mdeg then converted to 
(M1 cm1). Estimations of secondary structure were predicted
by using CDSSTR, SELCON3, andCONTINmethods included
in the DICHROWEB server (34), or using the K2D3 method
(35).
SEC-MALS analyses
Purified UbiK and copurified UbiK–UbiJ P1 and P2 were
analyzed using an HPLC-MALS system (Shimadzu) equipped
with three detectors, the light scattering detector (mini DAWN
TREOS system,Wyatt Technology), the refractive index detec-
tor (Optilab T-rEX, Wyatt Technology), and the UV detector
from HPLC (SPD-20A, Shimadzu). 200-g samples of UbiK
and UbiK–UbiJ P1 and P2 were injected in a Superdex 200
10/300 GL Increase column (GE Healthcare Life Sciences)
equilibrated in 50 mM Tris-Cl, pH 7.5, 150 mMNaCl buffer at a
flow rate of 0.5 ml min1. Molar masses of proteins were cal-
culated using ASTRA 6.1 software (Wyatt Technology) using a
refractive index increment (dn/dc) value of 0.183 ml g1.
Molecular weights of UbiK and UbiJ within the UbiK–UbiJ
complexes were determined by using the protein-conjugate
method. This method is based on the use of the three signals
(light scattering, absorbance, and differential refractive index)
to determine the molecular weight of the protein and of the
conjugate (DNA, RNA, glycosylation, detergent etc.) in com-
plex. Formalism of the protein-conjugate method was
described in Veesler et al. (36) with a protein–detergent com-
plex. By analogy, the system can be applied to a protein
A–protein B complex if mass extinction coefficient are differ-
ent (A is 2 or 3 times higher than B). As dn/dc of protein is
relatively constant (37), dn/dc were fixed to 0.183 ml g1.  is
the weight proportion of protein A, 1- corresponds to the
weight proportion of protein B. CA and CB are the respective
weight concentrations of proteins A and B.
CAB 	 CA 
 1  CB (Eq. 1)
dndc
AB
	 dndc A 
 1  dndc
B
(Eq. 2)
Using Equation 3, the concentration ofCAB can be expressed
as the following.
CAB 	
n
dndc
AB
	
n
dndc
A

 1  adndc
B
(Eq. 3)
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Where n is the variation of refractive index. Mass extinc-
tion coefficient of AB complex can be expressed as shown.
AB 	 A 
 1  B (Eq. 4)
By using Beer-Lambert equation and Equation 4, CAB can be
expressed as shown.
CAB 	
OD280nm
A
 1 B
(Eq. 5)
By using Equations 3 and 5, we obtain,
n
dndc
A

 1  dndc
B
	
OD280nm
A
 1 B
(Eq. 6)
For which  can be inferred.
 	
OD280nmdndc
B
 nB
nA B
 OD280nmdndc
A
 dndc
B
 (Eq. 7)
As dn/dc are identical, the term OD280nm((dn/dc)A  (dn/
dc)B) is negligible. Therefore, the terms , 1-, CA, and CB can
be calculated by the protein-conjugatemethod and can be used
to determine the molecular weights of protein A and protein B
in a AB complex if A and B are significatively different. Con-
cerning UbiK and UbiJ complexes, the UbiJ extinction coeffi-
cient (0.951 ml/(mg cm)) was predicted from the protein
amino acid sequences with the ProtParam tool (expasy.org/
protparam/) and UbiK extinction coefficient was determined
experimentally (0.059 ml/(mg cm)) using the “UV extension
from RI peak” method included in the ASTRA software.
Analytical ultracentrifuge (AUC)
Sedimentation velocity experiments were conducted with a
Beckman XL-I (Beckman-Coulter, Palo Alto, CA) AUC using
an An-50Ti rotor. Increasing concentrations of UbiK and
UbiK–UbiJ complexes P1 and P2 were loaded into Epon char-
coal-filled two-sector 12-mm path length cells. 400 l of sam-
ples and 410 l of buffer (50 mM Tris-HCl, pH 7.5, 150 mM
NaCl) were centrifuged at 42,000 rpm (128,297
 g) and 20 °C.
Absorbance at 280 nm and interference scans were collected
every 5 min and sedimentation velocity data were analyzed
using SEDFIT software (38). Viscosity and density parameters
were measured by using, respectively, a Anton Paar microvis-
cosimeter and density meter (DMA 4500). Partial specific vol-
umes of proteins were predicted by SEDNTERP software.
Contrary to Multi-Signal Sedimentation Velocity experi-
ments (39), which require 3 signals (2 different wavelengths in
absorbance and interferometry) to determine protein stoichi-
ometry, the present case is easier because the extinction coeffi-
cient of UbiK is close to zero (see SEC-MALS under “Results”).
So the interferometric signal (J) is due to both complex com-
ponents, whereas the absorbance signal is only due to UbiJ.
JUbiJ/UbiK, JUbiJ, and JUbiK correspond to fringes displaced,
respectively, due to the UbiJ–UbiK complex, UbiJ and UbiK.
IF UbiJ, IF UbiK correspond to molar increments of UbiJ and
UbiK in Rayleigh interferometry and UbiJ corresponds to a
molar extinction coefficient at 280 nm (all three last parameters
are predicted thanks to calculator module of SEDFIT software
by using protein sequences). l is the path length of analytical
ultracentrifugation centerpiece (1.2 cm).
JUbiJ/UbiK 	 JUbiJ 
 JUbiK (Eq. 8)
Thanks to Equation 8 of Padrick (39), we can write the
following.
JUbiJ   IF UbiJ l CUbiJ and
(Eq. 9)
JUbiK   IF UbiK l CUbiK
As only UbiJ absorbs we can apply the Beer-Lambert
equation.
OD280nm	 UbiJ l CUbiJ (Eq. 10)
OD280 nm is the optical density at 280 nm. Finally, by com-
bining Equations 8–10, we obtain the following.
JUbiJ/UbiK   IF UbiJ lOD280nml CUbiJ 	 JUbiK (Eq. 11)
JUbiJ/UbiK   IF UbiJOD280nmCUbiJ 
IF UbiK l
 CUbiK (Eq. 12)
After integration of each peak obtained in c(s) distribution by
SEDFIT,JUbiJ/UbiK, OD280 nm are determined,CUbiJ andCUbiK
are calculated to obtain the molar ratio of UbiK and UbiJ in
UbiK–UbiJ complex.
Fluorescence sedimentation velocity experiments were per-
formed thanks to the Aviv fluorescence detection system (AU-
FDS) and UbiK was labeled by monolith NT-115 Blue NHS
(Nanotemper Technology) according to the manufacturer’s
instructions. Labeled protein was diluted from 60 nM to 3 pM
with the buffer cited previously; to prevent protein adsorption,
BSA was added at a final concentration of 0.1 mg/ml for the
concentration of labeled UbiK below 1 nM. To study the olig-
omeric state of UbiK at concentrations higher than 60 nM,
unlabeled UbiK was added to 60 nM fluorescent protein to
reach the desired concentration. Samples were sedimented
in the same conditions used for absorbance/interference
experiments except no reference is required during fluores-
cence experiments.
Infection ofmacrophages with S. enterica strains
RAW264.7 macrophages were seeded at a density of 4
 105
cells per well in 6-well tissue culture plates containing DMEM
with 10% fetal bovine serum (FBS) (HyClone). S. enterica
strains were grown overnight with or without oxygen and at 30
or 37 °C as indicated in the figure legends. Afterward, these
cultures were opsonized in DMEM containing FBS and normal
mouse serum (10%, Perbio) for 30 min. Bacteria were added to
themonolayers at amultiplicity of infection 10:1, centrifuged at
400
 g for 5 min at 4 °C, and incubated for 30 min at 37 °C in
5% CO2. The macrophages were washed three times, and incu-
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bated with DMEM containing FBS and 100 g/ml of gentami-
cin for 60 min, after which the gentamicin concentration was
decreased to 10g/ml for the remainder of the experiment. For
enumeration of intracellular bacteria, macrophages were
washed two times with PBS, lysed with 0.1% Triton X-100, and
a dilution series was plated on LB agar.
Virulence assays inmice
Eight-week-old female BALB/c mice (Charles River Labora-
tories) were inoculated intraperitoneally with equal amounts of
S. enterica wild-type and ubiKmutant strains for a total of 105
bacteria permouse. The spleens were harvested 48 h after inoc-
ulation, then homogenized. Bacteria were recovered and enu-
merated after plating a dilution series onto LB agar and LB agar
with kanamycin. CI were determined for eachmouse. The CI is
defined as the ratio between the ubiK mutant and wild-type
strains within the output (bacteria recovered from the mouse
after infection) divided by their ratios within the input (initial
inoculum).
Statistical methods
Results are presented as mean  S.E. Data sets were com-
pared by unpaired two-tailed t test or an analysis of variance
using GraphPad Prism 7 software.
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